The ASCOT trial is supported by funding from:

Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE)

BHP Foundation

Chong Kun Dang Pharmaceutical Corporation

Health Research Council of New Zealand

Hospital Research Foundation

Macquarie Group Foundation

Medical Research Future Fund

Minderoo Foundation

NSW Health

NSW Office for Health and Medical Research

Pratt Foundation

Royal Brisbane and Women’s Hospital Foundation

The Common Good (The Prince Charles Hospital Foundation)

The Russell and Womersley Foundation.

Victorian Government 

Wesley Medical Research